Company Filing History:
4 out of 3,539 
3 out of 1,932 
Years Active: 2019-2025
Title: Scott Durum: Innovator in Cancer Treatment
Introduction
Scott Durum is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative research and development of therapeutic antibodies.
Latest Patents
Scott Durum holds a total of 4 patents. His latest patents include the development of IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia. This patent discloses antibodies and antigen binding fragments that specifically bind to IL-7Rα. It also provides nucleic acids encoding these antibodies and methods for detecting cancer cells that express IL-7Rα. Additionally, he has developed peptide hydrogels that utilize novel anionic amphiphilic β-hairpin peptides. These peptides self-assemble to form a reversible gel-sol hydrogel, which can be used to deliver protein therapeutics and cells effectively.
Career Highlights
Throughout his career, Scott Durum has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University System of Maryland. His work has significantly impacted the development of cancer therapies.
Collaborations
Scott has collaborated with several professionals in his field, including Scott Walsh and Julie Hixon. Their combined expertise has contributed to the advancement of innovative solutions in cancer treatment.
Conclusion
Scott Durum is a dedicated inventor whose work in developing targeted cancer therapies has the potential to improve patient outcomes significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.